Yahoo Finance • last month
SINGAPORE, Aug. 28, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary technologies to develop n... Full story
Yahoo Finance • 2 months ago
* Clinical-stage biopharmaceutical company CytoMed Therapeutics (NASDAQ:GDTC [https://seekingalpha.com/symbol/GDTC]) entered into [https://seekingalpha.com/pr/20204376-cytomed-therapeutics-limited-announces-at-the-market-atm-offering-... Full story
Yahoo Finance • 2 months ago
SINGAPORE, Aug. 18, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary technologies to develop n... Full story
Yahoo Finance • 3 months ago
SINGAPORE, July 21, 2025 (GLOBE NEWSWIRE) -- Further to our announcement filed on Form 6-K on November 20, 2024, CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based clinical stage biopharmaceutical compa... Full story
Yahoo Finance • 4 months ago
* CytoMed Therapeutics (NASDAQ:GDTC [https://seekingalpha.com/symbol/GDTC]) may offer up to $50M in securities under a new shelf registration. * Securities may include ordinary shares, warrants, debt, rights, share purchase units, and... Full story
Yahoo Finance • 8 months ago
SINGAPORE, Feb. 06, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or the “Company”) today released a letter to shareholders from the Chairman of the Company’s Board of Directors (the “Board”) as it welco... Full story
Yahoo Finance • last year
Emerging Growth MIAMI, Sept. 25, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com, a leading independent small cap media portal, announces the schedule of the 75th Emerging Growth Conference on September 25 & 26, 2024. The Emerging Growth Con... Full story